Hindustan Foods Ltd

Hindustan Foods Ltd

₹ 500 0.00%
24 Apr 10:47 a.m.
About

Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories

Key Points

Acquired by Van group[1] Hindustan food limited (HFL) started a joint venture between Glaxo smith kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd got acquired by Vanity Case India Pvt. Ltd. and the latter bought 74.45% of the paid-up share capital.

  • Market Cap 5,726 Cr.
  • Current Price 500
  • High / Low 632 / 461
  • Stock P/E 73.2
  • Book Value 36.5
  • Dividend Yield 0.00 %
  • ROCE 19.0 %
  • ROE 19.0 %
  • Face Value 2.00

Pros

  • Company has delivered good profit growth of 59.3% CAGR over last 5 years
  • Company's median sales growth is 56.9% of last 10 years

Cons

  • Stock is trading at 13.7 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -1.04%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Food - Processing - Indian

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
384 491 457 471 527 562 565 597 627 595 534 585 643
362 462 431 442 498 531 532 561 587 557 498 544 597
Operating Profit 22 29 26 29 29 31 33 36 40 38 36 41 46
OPM % 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% 7% 7% 7%
1 1 1 1 2 1 1 1 1 2 1 2 2
Interest 5 5 5 5 5 4 6 7 7 7 7 8 10
Depreciation 4 5 5 6 6 6 7 7 7 7 8 8 9
Profit before tax 13 21 17 19 19 22 21 23 27 25 22 27 28
Tax % 5% 35% 35% 36% 35% 34% 35% 26% 35% 36% 19% 19% 21%
13 13 11 12 13 15 14 17 17 16 18 22 23
EPS in Rs 1.18 1.27 1.05 1.15 1.18 1.29 1.23 1.50 1.54 1.45 1.58 1.91 2.00
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Sep 2012 Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
7 6 3 17 24 38 139 492 772 1,407 2,021 2,383 2,357
7 6 4 23 22 35 128 459 716 1,317 1,905 2,236 2,196
Operating Profit -1 -0 -0 -6 2 3 10 33 56 90 115 147 161
OPM % -9% -0% -15% -33% 9% 8% 7% 7% 7% 6% 6% 6% 7%
0 0 -0 11 0 0 1 1 1 3 5 5 6
Interest 1 1 1 2 1 1 1 8 11 19 20 27 32
Depreciation 0 0 0 1 1 1 1 7 11 19 24 29 33
Profit before tax -2 -1 -1 2 -0 1 9 18 35 54 77 96 103
Tax % -0% -4% -0% -0% 2,980% 19% 27% 35% 34% 28% 35% 33%
-2 -1 -1 2 1 1 6 12 23 39 50 65 78
EPS in Rs -0.66 -0.48 -0.53 1.00 0.58 0.10 0.97 1.76 2.14 3.71 4.44 5.72 6.94
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: 80%
5 Years: 77%
3 Years: 46%
TTM: 0%
Compounded Profit Growth
10 Years: 45%
5 Years: 59%
3 Years: 42%
TTM: 25%
Stock Price CAGR
10 Years: 52%
5 Years: 44%
3 Years: 7%
1 Year: -16%
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 18%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Sep 2012 Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 5 5 5 5 5 13 13 13 21 21 23 23 23
Reserves -7 -8 -9 -7 -5 19 24 51 166 235 285 349 389
Preference Capital 2 2 2 2 2 -0 1 1 1 2 2 2
9 16 16 10 11 5 32 98 164 218 272 345 386
4 5 8 9 8 13 48 104 189 266 306 360 389
Total Liabilities 12 19 20 17 19 50 118 266 540 741 886 1,076 1,187
3 4 8 9 9 9 39 133 250 308 396 402 462
CWIP 1 5 3 2 2 3 3 0 26 53 9 45 12
Investments -0 -0 -0 -0 -0 -0 -0 -0 3 3 7 80 80
8 10 9 6 8 38 75 133 261 377 474 549 632
Total Assets 12 19 20 17 19 50 118 266 540 741 886 1,076 1,187

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Sep 2012 Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0 -1 3 1 1 -5 -5 -5 17 73 54 102
-1 -5 -3 -1 -1 -14 -19 -40 -145 -91 -103 -167
1 6 -0 0 0 24 26 43 153 34 32 47
Net Cash Flow 0 0 -0 -0 -0 5 2 -2 24 16 -17 -18

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Sep 2012 Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 186 224 390 47 56 66 76 32 18 13 13 13
Inventory Days 158 136 295 108 37 90 139 54 74 58 52 61
Days Payable 258 183 387 184 103 166 237 85 94 74 60 58
Cash Conversion Cycle 86 177 298 -29 -10 -10 -21 1 -2 -3 5 16
Working Capital Days 136 134 107 -9 13 36 51 6 11 16 25 27
ROCE % -10% -2% -6% 34% 8% 7% 19% 22% 18% 18% 18% 19%

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
62.62% 62.62% 62.62% 64.85% 64.85% 64.85% 64.85% 64.85% 64.85% 64.85% 64.85% 63.82%
6.58% 6.57% 6.50% 6.13% 6.04% 6.04% 6.57% 6.56% 6.59% 6.58% 6.70% 6.70%
6.96% 6.94% 6.92% 6.53% 6.53% 6.55% 6.55% 6.64% 6.58% 6.03% 5.96% 7.18%
23.84% 23.86% 23.95% 22.50% 22.59% 22.56% 22.04% 21.94% 22.00% 22.54% 22.50% 22.30%
No. of Shareholders 35,03638,04838,44637,07838,45950,57653,71160,48969,98880,58786,14785,364

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls